Paolo Martelletti

Professor of Research

Università degli Studi di Roma La Sapienza Facoltà di Medicina e Psicologia

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Paolo Martelletti is a Professor of Research at Università degli Studi di Roma La Sapienza Facoltà di Medicina e Psicologia, Italy. His research primarily focuses on migraine treatment and headache management, with recent publications addressing topics such as the efficacy of Onabotulinumtoxin-A for chronic migraine in children, neurotransmitter imbalances in various headache types, and the implications of menopause on migraine treatment. He also explores the latest advancements in neuromodulation and therapeutic strategies within the field.

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (6)

Marta Waliszewska-Prosół

Wroclaw Medical University

POLAND

View details

Enrico Bentivegna

Sapienza University

ITALY

View details

Lanfranco Pellesi

DENMARK

View details

Fabrizio Ricci

ITALY

View details

Marcin Straburzyński

University of Warmia and Mazury in Olsztyn

POLAND

View details

matilde leonardi

Fondazione IRCCS Istituto Neurologico Carlo Besta

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Paolo Martelletti

Research Interests

Explore related searches

Contact this professor

About

Articles (29)

Neurotransmitter Imbalance in Cluster Headache: A Systematic Review of Mechanisms and Therapeutic Targets

Neurotransmitter Imbalance in Tension-Type Headache: A Systematic Review of Mechanisms and Therapeutic Targets

Head-to-head relief: ubrogepant, rimegepant, and zavegepant in migraine treatment

Menopause, Perimenopause, and Migraine: Understanding the Intersections and Implications for Treatment

Onabotulinumtoxin-A for Chronic Migraine in Children and Adolescents: A Narrative Review of Current Evidence and Clinical Perspectives

Translational Impact of Genetics and Epigenetics of CGRP System on Chronic Migraine Treatment with Onabotulinumtoxin A and Other Biotech Drugs

Neuromodulation in Chronic Migraine: Evidence and Recommendations from the GRADE Framework

Therapeutic barriers for headache management: issues facing the global north and global south in 2024

Real-world effectiveness of fremanezumab in patients with migraine switching from another mAb targeting the CGRP pathway

A proposal of actions for stakeholders and policy makers to address the global burden of headache disorders by 2030: why is this important for global health?

Placebo responses vary by route of administration in migraine prevention trials. What does this mean?

Rimegepant and atogepant: novel drugs providing innovative opportunities in the management of migraine

Situational prevention in migraine: are we doing the right thing?

Clinical Conditions Targeted by OnabotulinumtoxinA in Different Ways in Medicine

The preclinical discovery and development of atogepant for migraine prophylaxis

Switching CGRP(r) MoAbs in migraine: what evidence?

Potential benefits and possible risks of CGRP-targeted multitherapy in migraine

Targeting the PACAP-38 pathway is an emerging therapeutic strategy for migraine prevention

Comparative Insights into Physiotherapy Expectations Among Chronic Migraine Patients with and without OnabotulinumtoxinA Treatment: A Case–Control Study

Lessons Learned from the Lessons Learned in Public Health during the First Years of COVID-19 Pandemic

Emerging experimental drugs in clinical trials for migraine: observations and key talking points

Antiseizure medications as migraine preventatives: a call for action for a teratogenic and neurodevelopmental risk removal

Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome

The Migraine Stigma Kaleidoscope View

Common Clinical and Molecular Pathways between Migraine and Sarcoidosis

New Migraine Drugs for Older Adults

One Health for Headaches: A Clinical Scientist Residence Project

Effects of spinal stabilization exercises delivered using telerehabilitation on outcomes in patients with chronic neck pain: a randomized controlled trial

COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache

Collaborators (6)

Marta Waliszewska-Prosół

Enrico Bentivegna

Lanfranco Pellesi

Fabrizio Ricci

Marcin Straburzyński

matilde leonardi

Make your next move.